BAFNAPH

Bafna Pharmaceuticals Share PriceBafna Pharmaceuticals

₹82.00
1.8 (2.24%)
As on 31 March, 2023 | 22:32 BSE: 532989 NSE: BAFNAPH

Bafna Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Bafna Pharmaceuticals

Start SIP

Bafna Pharmaceuticals Share Price

  • Over 1 Month -14.49%
  • Over 3 Month -18.61%
  • Over 6 Month -19.57%
  • Over 1 Year -35.25%

Bafna Pharmaceuticals Key Statistics

P/E Ratio 39.2
PEG Ratio -0.9
Market Cap Cr 194
Price to Book Ratio 3.1
EPS 3.1
Dividend 0
Relative Strength Index 34.95
Money Flow Index 34.39
MACD Signal -2.65
Average True Range 3.9

Bafna Pharmaceuticals Investment Rating

  • Master Rating:
  • Bafna Pharmaceuticals has an operating revenue of Rs. 88.09 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 6% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 20 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bafna Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 34221715
Operating Expenses Qtr Cr 31191516
Operating Profit Qtr Cr 432-1
Depreciation Qtr Cr 1111
Interest Qtr Cr 1000
Tax Qtr Cr 0000
Net Profit Qtr Cr 321-1

Bafna Pharmaceuticals Technicals

EMA & SMA

Current Price
₹82.
1.8 (2.24%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 86.92
  • 50 Day
  • 91.49
  • 100 Day
  • 95.98
  • 200 Day
  • 103.06
  • 20 Day
  • 87.96
  • 50 Day
  • 92.66
  • 100 Day
  • 96.67
  • 200 Day
  • 103.12

Bafna Pharmaceuticals Resistance and Support

PIVOT
₹81.32
Resistance
First Resistance 84.59
Second Resistance 88.97
Third Resistance 92.24
RSI 34.96
MFI 34.39
MACD Single Line -2.65
MACD -3.32
Support
First Resistance 76.94
Second Resistance 73.67
Third Resistance 69.29

Bafna Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,436 143,600 100
Week 1,381 138,050 100
1 Month 1,908 190,840 100
6 Month 1,371 137,131 100

Bafna Pharmaceuticals Result Highlights

Bafna Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Bafna Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 71.22 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2021. Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698.
Market Cap 194
Sales 88
Shares in Float 0.24
No of funds 1
Yield
Book Value 3.09
U/D Vol ratio 1
LTDebt / Equity 13
Alpha -0.17
Beta 0.36

Bafna Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 90.02%90%90.12%
Foreign Portfolio Investors
Individual Investors 5.61%5.62%5.5%
Others 4.37%4.38%4.38%

Bafna Pharmaceuticals Management

Name Designation
Mrs. S Hemalatha Chairperson & Executive Director
Mr. Atul Sachdeva Non Exe.Non Ind.Director
Mrs. Akila C Raju Non Exe.Non Ind.Director
Ms. R Chitra Ind. Non-Executive Director
Mr. B Kamlesh Kumar Ind. Non-Executive Director
Mr. P K Sundaresan Ind. Non-Executive Director

Bafna Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bafna Pharmaceuticals FAQs

What is Share Price of Bafna Pharmaceuticals ?

Bafna Pharmaceuticals share price is ₹82 As on 31 March, 2023 | 22:18

What is the Market Cap of Bafna Pharmaceuticals ?

The Market Cap of Bafna Pharmaceuticals is ₹194 Cr As on 31 March, 2023 | 22:18

What is the P/E ratio of Bafna Pharmaceuticals ?

The P/E ratio of Bafna Pharmaceuticals is 39.2 As on 31 March, 2023 | 22:18

What is the PB ratio of Bafna Pharmaceuticals ?

The PB ratio of Bafna Pharmaceuticals is 3.1 As on 31 March, 2023 | 22:18

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number